Ferring Pharmaceuticals Inc recalls Menopur 75 IU, (menotropins for injection), packaged as a) 5 single dose vials of Menotropins for injection, 5 single d…
- Recall date
- March 2, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0299-2021
- FDA classification
- Class III
- Brand / firm
- Ferring Pharmaceuticals Inc
- Sold / distributed
- Distributed nationwide in the USA.
Why it was recalled
Failed pH specifications: Out of Specification pH results for 0.9% Sodium Chloride, USP
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Menopur 75 IU, (menotropins for injection), packaged as a) 5 single dose vials of Menotropins for injection, 5 single dose vials of 0.9% Sodium Chloride Injection, USP 2 mL, NDC 55566-7501-2; b) Professional Sample Kit: 3 single dose vials of Menotropins for injection, 3 single dose vials of 0.9% Sodium Chloride Injection, USP 2 mL, NDC 55566-7501-3; Rx Only, Manufactured for Ferring Pharmaceuticals Inc. Parsippany. NJ 07054. Diluent manufactured for Ferring Pharmaceuticals Inc.
Get recall alerts
Free email alert whenever Ferring Pharmaceuticals Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Ferring Pharmaceuticals Inc